Does thimerosal or other mercury exposure increase the risk for autism? A review of current literature

• Autorzy: Schultz S.T.
• Języki publikacji: EN

Abstrakty

EN

This report reviews current literature regarding the association of the pharmaceutical preservative thimerosal and other mercury exposures with the risk for autism. The evidence presented here does not support a causal association between autism and mercury exposure from the preservative thimerosal. The risk for autism from other mercury exposures such as from dental amalgam restorations or environmental mercury release into the atmosphere is ambiguous. Since mercury is a known neurotoxin, more research should be done to ensure that mercury exposure from any source does not contribute to autism.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2010
• Tom: 70
• Numer: 2
• Opis fizyczny: p.187-195,ref.

Twórcy

autor

Schultz S.T.

• Health Science School, University of Texas, San Antonio, TX, USA

Bibliografia

• American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th ed.). American Psychiatric Association, Washington, DC. Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B (2004) Thimerosal exposure in infants and develop­mental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics 114: 584-591.
• Becker KG, Schultz ST (2010) Similarities in features of autism and asthma and a possible link to acetaminophen use. Med Hypotheses 74: 7-11.
• Bellinger DC, Trachtenberg F, Barregard L, Tavares M, Cernichiari E, Daniel D, McKinlay S (2006) Neuropsychological and renal effects of dental amalgam in children. JAMA 295: 1775-1783.
• Centers for Disease Control and Prevention (2009) Autism Spectrum Disorders. [Available at: http://www.cdc.gov/ ncbddd/autism/index.html; accessed April 14, 2009].
• Croen LA, Matevia M, Yoshida CK, Grether, JK (2008) Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders. Am J Obstet Gynecol 199: 234.e1-e6.
• da Costa SL, Malm O, Dorea JG (2005) Breast-milk mer­cury concentrations and amalgam surface in mothers from Brasilia, Brazil. Biol Trace Elem Res 106: 145-51.
• Drasch G, Schupp I, Hofl H, Reinke R, Roider G (1994) Mercury burden of human fetal and infant tissues. Eur J Pediatr 153: 607-10.
• Drasch G, Aigner S, Roider G, Staiger F, Lipowsky G (1998) Mercury in human colostrum and early breast milk. Its dependence on dental amalgam and other fac­tors. J Trace Elem Med Biol 12: 23-7.
• Drexler H, Schaller KH (1998) The mercury concentration in breast milk resulting from amalgam fillings and dietary habits. Environ Res 77: 124-9.
• Durkin MS, Maenner MJ, Newschaffer CJ, Lee L-C, Cunniff CM, Daniels JL, Kirby RS, Leavitt L, Miller L, Zahorodny W, Schieve LA (2008) Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol 168: 1268-1276.
• Fido A, Al-Saad S (2005) Toxic trace elements in the hair of children with autism. Autism 9: 290-8.
• Fischer, RD (2004) Truth revealed: New scientific discover­ies regarding mercury in medicine and autism. Congressional testimony before the subcommittee on human rights and wellness, September 8, 2004. US House of Representatives. [Avaible at: http://www.whale.to/a/ fischer.pdf].
• Fombonne E (1999) The epidemiology of autistic disorder: a review. Psychol Med 29: 769-86.
• Fombonne E, Zakarian R, Bennett A, Meng L, McLean- Heywood D (2006) Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 118: e139-e150.
• Geier MR, Geier DA (2003a) Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communica­tion. Exp Biol Med (Maywood) 228: 660-664.
• Geier DA, Geier MR (2003b) An assessment of the impact of thimerosal on childhood neurodevelopmental disor­ders. Pediatr Rehabil 6: 97-102.
• Geier DA, Geier MR (2004) Neurodevelopmental disorders following thimerosal-containing childhood immuniza­tions: a follow-up analysis. Int J Toxicol 23: 369-76.
• Geier DA, Geier MR (2006) An evaluation of the effects of thimerosal on neurodevelopmental disorders reported fol­lowing DTP and Hib vaccines in comparison to DTPH vaccine in the United States. J Toxicol Environ Health 69: 1481-1495.
• Geier DA, Geier MR (2007) A prospective study of thimero- sal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders. J Matern Fetal Neonatal Med 20: 358-390.
• Geier DA, Kern JK, Geier MR (2009) A prospective study of prenatal mercury exposure from maternal dental amal­gams and autism severity. Acta Neurobiol Exp (Wars) 69: 189-197.
• Goodman MJ, Nordin J (2006) Vaccine Adverse Event Reporting System source: a possible source of bias in longitudinal studies. Pediatrics 117: 387-390.
• Grandjean P, Weihe P, and White RF, Debes F (1998) Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. Environ Res 77: 165­172.
• Heron J, Golding J, ALSPAC Study Team (2004) Thimerosal exposure in infants and developmental disorders: a pro­spective cohort study in the United Kingdom does not support a causal association. Pediatrics 114: 577-83.
• Hertz-Picciotto I, Green PG, Delwiche L, Hansen R, Walker C, Pessah IN (2010) Blood mercury concentrations in CHARGE. Study children with and without autism. Environ Health Perspect 118: 161-166.
• Holmes A, Blaxill M, Haley B (2003) Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol 22: 277-285.
• Hviid A, Stellfeld M, Wohlfahrt J, Melbye M (2003) Association between thimerosal-containing vaccine and autism. JAMA 290: 1763-6.
• Institute of Medicine of the National Academies (2004) Immunization safety review: vaccines and autism. The National Academies Press, Washington, DC, USA.
• Lawler CP, Croen LA, Grether JK, Van de Water J (2004) Identifying environmental contributions to autism: pro­vocative clues and false leads. Ment Retard Dev Disabil Res Rev 10: 292-302.
• Madsen KM, Lauritsen MB, Pedersen CB, Thorsen P, Plesner AM, Andersen PH, Mortensen PB (2003) Thimerosal and the occurrence of autism: negative eco­logical evidence from Danish population-based data. Pediatrics 112: 604-606.
• Miles JH, Takahashi TN (2007) Lack of association between Rh status, Rh immune globulin in pregnancy and autism. Am J Med Genet A 143A: 1397-1407.
• Oskarsson A, Schultz A, Skerfving S, Hallen IP, Ohlin B, Lagerkvist BJ (1996) Total and inorganic mercury in breast milk in relation to fish consumption and amalgam in lactating women. Arch Environ Health 51: 234-241.
• Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C (2006) Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place 12: 203-209.
• Parker SK, Schwartz B, Todd J, Pickering LK (2004) Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 114: 793-804.
• Roberts HW, Charlton DG (2009) The release of mercury from amalgam restorations and its health effects: a review. Oper Dent 34: 605-614.
• Schechter R, Grether JK (2008) Continuing increases in autism reported to California's Developmental Services System: mercury in retrograde. Arch Gen Psychiatry 65: 19-24.
• Schultz ST, Klonoff-Cohen HS, Wingard DL, Akshoomoff NA, Macera CA, Ji M, Bacher C (2006) Breastfeeding, infant formula supplementation, and Autistic Disorder: the results of a parent survey. Int Breastfeed J 1: 16.
• Schultz ST (2008) Autism Risk. VDM Verlag Dr. Müller AG 6 Co. KG. Saarbrücken, Germany.
• Schultz ST, Klonoff-Cohen HS, Wingard DL, Akshoomoff NA, Macera CA, Ji M (2008) Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: the results of a parent survey. Autism 12: 293-307.
• The Autism Society (2010) Autism society - improving the lives of all affected by autism. [Available at: http://www. autism-society.org/; accessed June 1st, 2010].
• Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F (2007) Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 357: 1281-92.
• Ursinyova M, Masanova V (2005) Cadmium, lead and mer­cury in human milk from Slovakia. Food Addit Contam 22: 579-589.
• US Food and Drug Administration (2009) Vaccine safety and availability: Thimerosal in vaccines. [Available at: http://www.fda.gov/BiologicsBloodVaccines/ SafetyAvailability/VaccineSafety/UCM096228; accessed October 23, 2009].
• Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, Chen RT; Vaccine Safety Datalink Team (2003) Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 112: 1039-1048.
• Verstraeten T (2004) Thimerosal, the Centers for Disease Control and Prevention, and GlaxoSmithKline. Pediatrics 113: 932.
• Vimy MJ, Hooper DE, King WW, Lorscheider FL (1997) Mercury from maternal "silver" tooth fillings in sheep and human breast milk. A source of neonatal exposure. Biol Trace Elem Res 56: 143-152.
• Young HA, Geier DA, Geier MR (2008) Thimerosal exposure in infants and neurodevelopmental disor­ders: as assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci 271: 110-118.

Uwagi

PL

Rekord w opracowaniu